LITS
Lite Strategy, Inc.
There isn't enough reported data to score LITS yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
LITS Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Stable | |
| Unavailable | |
| Strong |
LITS's balance sheet is currently strong, and its profitability is stable, but its revenue is weak. There isn't enough data to rate its cash flow.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
LITS PE Valuation
LITS has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
LITS Forward outlook
There aren't enough analyst estimates for LITS to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
LITS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.46 | -$0.15 |
| Q2 2026 | -$2.06 | +$0.33 |
| Q1 2026 | -$2.00 | +$2.75 |
| Q4 2025 | -$1.73 | +$4.00 |
| Q3 2025 | -$1.31 | +$5.68 |
| Q2 2025 | -$2.39 | -190% |
| Q1 2025 | -$4.75 | -226% |
| Q4 2024 | -$5.73 | -303% |
LITS is still losing money, but far less than before: $1.46 per share over the past year, against $14.80 at its worst in early 2021.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over LITS on earnings quality, reporting a profit while its opponent remains loss making.
LITS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2023 | $65.3M | +648% |
| Q2 2023 | $1.5M | -87% |
| Q1 2023 | $5.9M | -39% |
| Q4 2022 | $32.7M | +177% |
| Q3 2022 | $8.7M | +13% |
| Q2 2022 | $11.4M | -41% |
| Q1 2022 | $9.7M | +301% |
| Q4 2021 | $11.8M | +29% |
LITS's revenue has slid since its 2023 peak: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2023 | 85% | +293 points |
| Q2 2023 | -760% | -619 points |
| Q1 2023 | -278% | -56 points |
| Q4 2022 | 27% | +176 points |
| Q3 2022 | -209% | +51 points |
| Q2 2022 | -142% | -124 points |
| Q1 2022 | -222% | +691 points |
| Q4 2021 | -149% | +61 points |
LITS's operating margin was 85% last quarter, up 293 points from the same quarter a year ago, near the top of its range since 2019.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
LITS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.2M | +$2.3M |
| Q2 2026 | -$1.2M | +$1.3M |
| Q1 2026 | -$1.5M | +$1.7M |
| Q3 2025 | -$4.5M | +$6.9M |
| Q2 2025 | -$2.5M | +$15.5M |
| Q1 2025 | -$3.3M | -$339K |
| Q3 2024 | -$11.5M | +$7M |
| Q2 2024 | -$18M | -$6.7M |
LITS has burned cash in almost every quarter: −$7M over the past year, against −$22M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over LITS on cash generation, producing positive trailing cash flow while its opponent burns cash.
LITS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2024 | -0.3x | Net Cash |
| Q1 2024 | -0.1x | Net Cash |
| Q4 2023 | -0.3x | Net Cash |
| Q3 2023 | -0.1x | Net Cash |
LITS has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
LITS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.6 | Neutral |
| Stochastic | 24.0 | Neutral |
LITS's weekly RSI is 40 (neutral) and its Stochastic is 24 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
LITS PE vs Healthcare Sector
| Metric | LITS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
LITS has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
LITS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.18 | 23% below |
| 20 week MA | $1.07 | 15% below |
| 50 week MA | $1.14 | 20% below |
| 100 week MA | $1.98 | 54% below |
| 200 week MA | $3.41 | 73% below |
LITS is in a downtrend: it's below all five of its weekly moving averages, and 73% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over LITS on trend strength, trading above more of its moving averages.
LITS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $43.4 | $58.0 | +34% |
| 2021 | $58.0 | $51.4 | -11% |
| 2022 | $51.4 | $5.00 | -90% |
| 2023 | $5.00 | $5.80 | +16% |
| 2024 | $5.80 | $2.44 | -58% |
| 2025 | $2.44 | $1.35 | -45% |
| 2026 YTD | $1.35 | $0.91 | -33% |
LITS has finished lower in four of the last six years. It's down 33% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over LITS on returns for 2026, with the stronger performance.